GlassScriptPhysician profile
Lauren P Hoffman
NPI 1043573538
$2,557.67
in general payments reported to CMS, 2019-2025
16 companies · $440 in 2025
The $440 reported for 2025 was more than what 96% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.59 · 2022: $647 · 2023: $873 · 2024: $543 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $928.42 | 2022-2025 | |
| Janssen Biotech, INC. | $457.94 | 2022-2025 | Stelara, Simponi Aria, Simponi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $385.29 | 2021-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $218.05 | 2021-2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $126.58 | 2022-2024 | Dupixent |
| Madrigal Pharmaceuticals | $77.88 | 2025 | Rezdiffra |
| Lilly USA, LLC | $76.90 | 2024-2025 | Omvoh |
| Merck Sharp & Dohme LLC | $65.81 | 2021-2025 | Dificid, Lynparza |
| Janssen Pharmaceuticals, INC | $64.59 | 2024 | Xarelto |
| Urogen Pharma, INC. | $52.08 | 2024 | |
| Redhill Biopharma INC. | $23.81 | 2022 | |
| Braintree Laboratories, INC. | $18.41 | 2022 | |
| Sumitomo Pharma America, INC. | $18.26 | 2024 | Orgovyx |
| Immunitybio, INC. | $17.91 | 2024 | |
| Teleflex LLC | $13.86 | 2024 | Urolift |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.